GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June...
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June...
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in...
BARCELONA, Spain, Sept. 20, 2024 /PRNewswire/ -- On September 19, at the HUAWEI Innovative Product Launch event in Barcelona, Spain,...
Join us for an enlightening and transformative experience at the Changing Face of Addiction Virtual Summit, where we bring together...